Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer

被引:183
|
作者
Madalinska, JB
Hollenstein, J
Bleiker, E
van Beurden, M
Valdimarsdottir, HB
Massuger, LF
Gaarenstroom, KN
Mourits, MJE
Verheijen, RHM
van Dorst, EBL
van der Putten, H
van der Velden, K
Boonstra, H
Aaronson, NK
机构
[1] Netherlands Canc Inst, Dept Gynecol, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Gynaecol, Amsterdam, Netherlands
[3] Acad Med Ctr, Dept Gynecol, Amsterdam, Netherlands
[4] Univ Nijmegen, Med Ctr, Dept Gynecol, Nijmegen, Netherlands
[5] Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol, Groningen, Netherlands
[7] Univ Utrecht, Med Ctr, Dept Gynecol, Utrecht, Netherlands
[8] Acad Hosp Maastricht, Dept Gynecol, Maastricht, Netherlands
[9] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
关键词
D O I
10.1200/JCO.2005.02.626
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Recommendations for women at high risk of ovarian cancer include periodic gynecologic screening (GS) and prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to determine the quality-of-life (QOL) effects of PBSO versus GS. Patients and Methods: Questionnaire data were obtained from 846 high-risk women who had participated in this nationwide, cross-sectional, observational study. Forty-four percent of the women had undergone PBSO, and 56% had opted for GS. Topics addressed by the questionnaire included generic QOL, cancer-specific distress, endocrine symptoms, and sexual functioning. Results: No statistically significant between-group differences were observed in generic QOL (Short Form-36), with women in both the PBSO and GS groups scoring similarly to the general population. Compared with GS, PBSO was associated with fewer breast and ovarian cancer worries (P < .001) and more favorable cancer risk perception (P < .05). However, the PBSO group reported significantly more endocrine symptoms (P < .001) and worse sexual functioning (P < .05) than the GS group. Eighty-six percent of women would choose PBSO again, and 63% would recommend it to a friend with familial risk of ovarian cancer. Conclusion: PBSO had no measurable adverse impact on generic QOL of high-risk women. The favorable effects of PBSO in terms of reduced cancer worries and low perceived cancer risk need to be weighed against the increase in endocrine and sexual symptoms. Balanced information will help clinicians and high-risk women to make informed decisions about the optimal preventive health strategy. © 2005 by American Society of Clinical Oncology.
引用
收藏
页码:6890 / 6898
页数:9
相关论文
共 50 条
  • [41] The effect of hormone therapy on breast density following risk-reducing salpingo-oophorectomy in women with an increased risk for breast and ovarian cancer
    van Barele, Mark
    Buis, Chistien C. M.
    Brood-van Zanten, Monique M. A.
    van Doorn, H. Lena C.
    Gaarenstroom, Katja N.
    Heemskerk-Gerritsen, Bernadette A. M.
    Hooning, Maartje J.
    de Hullu, Joanne
    Mourits, Marian J.
    Burger, Curt W.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (11): : 1307 - 1312
  • [42] Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer
    Meiser, B
    Tiller, K
    Gleeson, MA
    Andrews, L
    Robertson, G
    Tucker, KM
    [J]. PSYCHO-ONCOLOGY, 2000, 9 (06) : 496 - 503
  • [43] Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: A controlled observational study
    Michelsen, Trond M.
    Pripp, Are H.
    Tonstad, Serena
    Trope, Claes G.
    Dorum, Anne
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 82 - 89
  • [44] A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer
    Michelsen, Trond M.
    Dorum, Anne
    Dahl, Alv A.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 113 (01) : 128 - 133
  • [45] Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes
    Liu, Ying L.
    Breen, Kelsey
    Catchings, Amanda
    Ranganathan, Megha
    Latham, Alicia
    Goldfrank, Deborah J.
    Grisham, Rachel N.
    Long Roche, Kara
    Frey, Melissa K.
    Chi, Dennis S.
    Abu-Rustum, Nadeem
    Aghajanian, Carol
    Offit, Kenneth
    Stadler, Zsofia K.
    [J]. JCO ONCOLOGY PRACTICE, 2022, 18 (03) : 201 - +
  • [46] Clinical background and outcomes of risk-reducing salpingo-oophorectomy for patients with hereditary breast and ovarian cancer in Japan
    Nomura, H.
    Sekine, M.
    Yokoyama, S.
    Takeshima, N.
    Arai, M.
    Nakamura, S.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [48] ONCOLOGICAL OUTCOMES FOLLOWING RISK REDUCING BILATERAL SALPINGO-OOPHORECTOMY IN WOMEN DEEMED HIGH RISK FOR OVARIAN CANCER
    Smallwood, K.
    Huang, V.
    Phillips, A.
    Crockett, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A48 - A49
  • [49] BRCA Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art
    Sekine, Masayuki
    Nishino, Koji
    Enomoto, Takayuki
    [J]. CANCERS, 2021, 13 (11)
  • [50] Risk of Cardiovascular Disease in Women Who Underwent Salpingo-Oophorectomy to Prevent Hereditary Breast Ovarian Cancer: A Systematic Review and Meta-Analysis
    de Moraes, Francisco Cezar A.
    Souza, Maria Eduarda Cavalcanti
    Dal Moro, Lucca
    Rodrigues, Anna
    Donadon, Isabelle Batista
    Barbosa, Barbara Ferraz
    Pasqualotto, Eric
    [J]. CIRCULATION, 2023, 148